Mohsin Y. Meghji - Jan 1, 2023 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Director
Signature
/s/ Mohsin Y Meghji
Stock symbol
BIAF
Transactions as of
Jan 1, 2023
Transactions value $
$56,255
Form type
4
Date filed
7/6/2023, 04:15 PM
Previous filing
Mar 7, 2023
Next filing
Sep 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $18.8K +8.23K +11.84% $2.28 77.7K Jan 1, 2023 Direct F1
transaction BIAF Common Stock Award $18.7K +9.92K +12.77% $1.89 87.6K Apr 15, 2023 Direct F2
transaction BIAF Common Stock Award $18.7K +10.2K +11.69% $1.83 97.9K Jul 1, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant from bioAffinity Technologies, Inc. (the "Issuer") to Mr. Meghji of 8,227 restricted shares of common stock, par value $0.007 (the "Common Stock"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
F2 Represents a grant from the Issuer to Mr. Meghji of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Meghji continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
F3 Represents a grant from the Issuer to Mr. Meghji of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.